News

Article

Weirless Diaphragm Valves Eliminate Cross-Contamination

Watson-Marlow Fluid Technology Group’s ASEPCO Weirless Radial diaphragm valves eliminate dead legs and product entrapment.

Image courtesy of Watson-Marlow Fluid Technology Group.

Watson-Marlow Fluid Technology Group (WMFTG)’s ASEPCO Weirless Radial diaphragm valves use integral travel stops and a patented radial shoulder seal to completely isolate process fluids and eliminate dead legs and cross-contamination. Unlike weir-style diaphragm valves, which can introduce product entrapment and leakage, the weirless valves are contamination-free and feature a 180° flow path, with drainability in multiple orientations without leakage.

 

The weirless valves feature a clean, self-draining design with a simple clamp assembly that reduces change time from as much as 20 minutes (with a typical weir-type valve) down to a minute. The valves are easy to seal and inspect and never need retightening or adjustment. No tools are required for maintenance.

 

The valves offer installation flexibility for compact skids; more compact systems require less time to get up to temperature and achieve sterilization, thus improving efficiency of biopharmaceutical processes. Actuators on the valves have numerous options, including a control interface that enables users to use the weirless valve to control flow in process lines.

 

Source: Watson-Marlow Fluid Technology Group

 

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Related Videos
A global supply chain map, visualizing the complex network of transportation routes and distribution centers | Image Credit: © venusvi - stock.adobe.com
Shortcut from point A to point B | Image Credit: © Olivier Le Moal - stock.adobe.com
Wooden blocks spelling TARIFFS are placed on a map of North America, specifically over the United States and Mexico | Image Credit: © Rokas - stock.adobe.com
Simona Guidi, Associate Director, ProPharma
Behind the Headlines, Episode 18
Drug Digest: Patient Preference Drives Solid Dosage Trends
Behind the Headlines, Episode 17
Related Content